WNT5A and melanoma: In melanoma, Wnt5a activated the Wnt/Ca2+ pathway, leading to activated CDC42, cytoskeletal changes, and the rapid release of exosomes containing the immunomodulatory cytokine IL-6 and the proangiogenic factors IL-8, VEGF and MMP2 [65].